Literature DB >> 21520352

Damage to the cingulum contributes to Alzheimer's disease pathophysiology by deafferentation mechanism.

Marco Bozzali1, Giovanni Giulietti, Barbara Basile, Laura Serra, Barbara Spanò, Roberta Perri, Franco Giubilei, Camillo Marra, Carlo Caltagirone, Mara Cercignani.   

Abstract

This study investigates the differential contribution of gray matter (GM) atrophy and deafferentation through white matter (WM) damage in the clinical progression of Alzheimer's disease (AD). Thirty-one patients with probable AD, 23 with amnestic mild cognitive impairment (a-MCI), and 14 healthy subjects underwent MRI scanning at 3T. Voxel-based morphometry was used to assess regional GM atrophy in AD and a-MCI patients. Diffusion tensor-MRI tractography was used to reconstruct the cingulum bilaterally, and to quantify, voxel-by-voxel, its fractional anisotropy (FA) and mean diffusivity (MD) (measures of microscopic WM integrity). Atrophy of the cinguli was also assessed by means of jacobian determinants (JD) of local transformations. In AD patients, four clusters of reduced GM were found nearby the cinguli, in the posterior (PCC) and anterior cingulate cortex, and in the hippocampal/parahippocampal areas. Widespread areas of reduced FA and increased MD were found in the cinguli of both, AD and a-MCI patients. A region of macroscopic atrophy was detectable in AD patients only. Strong associations were found between local GM densities in the four identified clusters, and measures of micro- and (to a lesser extent) macroscopic damage of patients' cinguli. Linear regression analyses revealed that MD in the cinguli predicts patients' measures of episodic memory in combination with GM density of hippocampal/parahippocampal areas, and measures of global cognition in combination with GM density of the PCC. This study indicates that brain deafferentation though the cingulum is likely to play a remarkable role in progressive development of cognitive impairment in AD.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21520352      PMCID: PMC6870125          DOI: 10.1002/hbm.21287

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  53 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

3.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

4.  Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.

Authors:  Gaël Chételat; Victor L Villemagne; Pierrick Bourgeat; Kerryn E Pike; Gareth Jones; David Ames; Kathryn A Ellis; Cassandra Szoeke; Ralph N Martins; Graeme J O'Keefe; Olivier Salvado; Colin L Masters; Christopher C Rowe
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

5.  Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI.

Authors:  M Bozzali; M Franceschi; A Falini; S Pontesilli; M Cercignani; G Magnani; G Scotti; G Comi; M Filippi
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

6.  The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration.

Authors:  Béatrice Desgranges; Jean-Claude Baron; Catherine Lalevée; Bénédicte Giffard; Fausto Viader; Vincent de La Sayette; Francis Eustache
Journal:  Brain       Date:  2002-05       Impact factor: 13.501

7.  The Mini-Mental State Examination in Alzheimer's disease and multi-infarct dementia.

Authors:  E Magni; G Binetti; A Padovani; S F Cappa; A Bianchetti; M Trabucchi
Journal:  Int Psychogeriatr       Date:  1996       Impact factor: 3.878

Review 8.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

9.  Grey and white matter changes at different stages of Alzheimer's disease.

Authors:  Laura Serra; Mara Cercignani; Delia Lenzi; Roberta Perri; Lucia Fadda; Carlo Caltagirone; Emiliano Macaluso; Marco Bozzali
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

10.  Between session reproducibility and between subject variability of diffusion MR and tractography measures.

Authors:  E Heiervang; T E J Behrens; C E Mackay; M D Robson; H Johansen-Berg
Journal:  Neuroimage       Date:  2006-09-26       Impact factor: 6.556

View more
  28 in total

1.  Cardiorespiratory Fitness and White Matter Neuronal Fiber Integrity in Mild Cognitive Impairment.

Authors:  Kan Ding; Takashi Tarumi; David C Zhu; Benjamin Y Tseng; Binu P Thomas; Marcel Turner; Justin Repshas; Diana R Kerwin; Kyle B Womack; Hanzhang Lu; C Munro Cullum; Rong Zhang
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

2.  Free-water metrics in medial temporal lobe white matter tract projections relate to longitudinal cognitive decline.

Authors:  Derek B Archer; Elizabeth E Moore; Niranjana Shashikumar; Logan Dumitrescu; Kimberly R Pechman; Bennett A Landman; Katherine A Gifford; Angela L Jefferson; Timothy J Hohman
Journal:  Neurobiol Aging       Date:  2020-05-12       Impact factor: 4.673

3.  Disruption of thalamic connectivity in Alzheimer's disease: a diffusion tensor imaging study.

Authors:  Qing-Yong Zhu; Si-Wei Bi; Xiu-Ting Yao; Zhi-Yan Ni; Ying Li; Bo-Yu Chen; Guo-Guang Fan; Xiu-Li Shang
Journal:  Metab Brain Dis       Date:  2015-07-04       Impact factor: 3.584

4.  Brain tissue modifications induced by cholinergic therapy in Alzheimer's disease.

Authors:  Marco Bozzali; Geoff J M Parker; Barbara Spanò; Laura Serra; Giovanni Giulietti; Roberta Perri; Giuseppe Magnani; Camillo Marra; Maria G Vita; Carlo Caltagirone; Mara Cercignani
Journal:  Hum Brain Mapp       Date:  2012-06-19       Impact factor: 5.038

5.  Statins and brain integrity in older adults: secondary analysis of the Health ABC study.

Authors:  Neelesh K Nadkarni; Subashan Perera; Joseph T Hanlon; Oscar Lopez; Anne B Newman; Howard Aizenstein; Marshall Elam; Tamara B Harris; Stephen Kritchevsky; Kristine Yaffe; Caterina Rosano
Journal:  Alzheimers Dement       Date:  2015-01-12       Impact factor: 21.566

6.  Ex vivo T2 relaxation: associations with age-related neuropathology and cognition.

Authors:  Robert J Dawe; David A Bennett; Julie A Schneider; Sue E Leurgans; Aikaterini Kotrotsou; Patricia A Boyle; Konstantinos Arfanakis
Journal:  Neurobiol Aging       Date:  2014-02-06       Impact factor: 4.673

7.  PTPN11 Mutations in the Ras-MAPK Signaling Pathway Affect Human White Matter Microstructure.

Authors:  Mustafa Fattah; Mira M Raman; Allan L Reiss; Tamar Green
Journal:  Cereb Cortex       Date:  2021-02-05       Impact factor: 5.357

8.  Microstructural damage of the posterior corpus callosum contributes to the clinical severity of neglect.

Authors:  Marco Bozzali; Chiara Mastropasqua; Mara Cercignani; Giovanni Giulietti; Sonia Bonnì; Carlo Caltagirone; Giacomo Koch
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

9.  MRI markers for mild cognitive impairment: comparisons between white matter integrity and gray matter volume measurements.

Authors:  Yu Zhang; Norbert Schuff; Monica Camacho; Linda L Chao; Thomas P Fletcher; Kristine Yaffe; Susan C Woolley; Catherine Madison; Howard J Rosen; Bruce L Miller; Michael W Weiner
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

10.  Functional neural correlates of attentional deficits in amnestic mild cognitive impairment.

Authors:  Nicholas T Van Dam; Mary Sano; Effie M Mitsis; Hillel T Grossman; Xiaosi Gu; Yunsoo Park; Patrick R Hof; Jin Fan
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.